ERBB2 and breast carcinoma: Gene expression signatures based on microarray studies have distinguished breast cancer into various molecular intrinsic subtypes (luminal A, luminal B, HER2-like, basal-like, and normal-like); however, hormone receptor positivity remains the fundamental feature of this disease (9, 10).